Changes in the gut mycobiome in pediatric patients in relation to the clinical activity of Crohn's disease

BACKGROUND Numerous studies have shown that in Crohn’s disease (CD), the gut microbiota is of great importance in the induction and maintenance of inflammation in the gastrointestinal tract. Until recently, studies have focused almost exclusively on bacteria in the gut. Lately, more attention has been paid to the role of intestinal fungi. AIM To study the gut mycobiome analysis of pediatric patients with CD (in different stages of disease activity) compared to healthy children. METHODS Fecal samples were collected from patients: With active, newly diagnosed CD (n = 50); active but previously diagnosed and treated CD (n = 16); non-active CD and who were in clinical remission (n = 39) and from healthy volunteers (n = 40). Fungal DNA was isolated from the samples. Next, next generation sequencing (MiSeq, Illumina) was performed. The composition of mycobiota was correlated with clinical and blood parameters. RESULTS Candida spp. were overrepresented in CD patients, while in the control group, the most abundant genus was Saccharomyces. In CD patients, the percentage of Malassezia was almost twice that of the control (P < 0.05). In active CD patients, we documented a higher abundance of Debaryomyces hansenii (D. hansenii) compared to the non-active CD and control (P < 0.05) groups. Moreover, statistically significant changes in the abundance of Mycosphaerella, Rhodotorula, and Microidium were observed. The analyses at the species level and linear discriminant analysis showed that in each group it was possible to distinguish a specific species characteristic of a given patient population. Moreover, we have documented statistically significant correlations between: D. hansenii and patient age (negative); C. zeylanoides and patient age (positive); C. dubliniensis and calprotectin (positive); C. sake and calprotectin (positive); and C. tropicalis and pediatric CD activity index (PCDAI) (positive). CONCLUSION Mycobiome changes in CD patients, and the positive correlation of some species with calprotectin or PCDAI, give strong evidence that fungi may be of key importance in the development of CD.

[1]  H. Sokol,et al.  The ileal fungal microbiota is altered in Crohn's disease and is associated with the disease course , 2022, Frontiers in Medicine.

[2]  S. Jawhara.  How Gut Bacterial Dysbiosis Can Promote Candida albicans Overgrowth during Colonic Inflammation , 2022, Microorganisms.

[3]  M. Frąc,et al.  Changes of pectin structure and microbial community composition in strawberry fruit (Fragaria × ananassa Duch.) during cold storage. , 2022, Food chemistry.

[4]  F. Cominelli,et al.  Candida tropicalis Infection Modulates the Gut Microbiome and Confers Enhanced Susceptibility to Colitis in Mice , 2021, Cellular and molecular gastroenterology and hepatology.

[5]  T. Bintsis.  Yeasts in different types of cheese , 2021, AIMS microbiology.

[6]  T. Gosiewski,et al.  Association of Fungi and Archaea of the Gut Microbiota with Crohn’s Disease in Pediatric Patients—Pilot Study , 2021, Pathogens.

[7]  D. Underhill,et al.  Debaryomyces is enriched in Crohn’s disease intestinal tissue and impairs healing in mice , 2021, Science.

[8]  U. Ijaz,et al.  Inter-kingdom relationships in Crohn’s disease explored using a multi-omics approach , 2021, Gut microbes.

[9]  X. Qiu,et al.  Characterization of fungal and bacterial dysbiosis in young adult Chinese patients with Crohn’s disease , 2020, Therapeutic advances in gastroenterology.

[10]  Darren L. Smith,et al.  The Impact of NOD2 Genetic Variants on the Gut Mycobiota in Crohn’s Disease Patients in Remission and in Individuals Without Gastrointestinal Inflammation , 2020, Journal of Crohn's & colitis.

[11]  N. Price,et al.  Health and disease markers correlate with gut microbiome composition across thousands of people , 2020, Nature Communications.

[12]  D. Underhill,et al.  Malassezia spp. induce inflammatory cytokines and activate NLRP3 inflammasomes in phagocytes , 2020, Journal of leukocyte biology.

[13]  A. Dębska-Ślizień,et al.  Mycobiota of the human gastrointestinal tract , 2020 .

[14]  M. Duplaga,et al.  Quantitative changes in selected bacteria in the stool during the treatment of Crohn's disease. , 2020, Advances in medical sciences.

[15]  Y. Arafat,et al.  Long-Term Monoculture Negatively Regulates Fungal Community Composition and Abundance of Tea Orchards , 2019, Agronomy.

[16]  M. Zali,et al.  Altered fecal bacterial composition correlates with disease activity in inflammatory bowel disease and the extent of IL8 induction. , 2019, Current research in translational medicine.

[17]  S. Targan,et al.  Malassezia Is Associated with Crohn's Disease and Exacerbates Colitis in Mouse Models. , 2019, Cell host & microbe.

[18]  H. Sokol,et al.  The gut mycobiota: insights into analysis, environmental interactions and role in gastrointestinal diseases , 2019, Nature Reviews Gastroenterology & Hepatology.

[19]  T. Gosiewski,et al.  Dependence of Colonization of the Large Intestine by Candida on the Treatment of Crohn’s Disease , 2019, Polish journal of microbiology.

[20]  Y. Naito,et al.  Gut microbiota in the pathogenesis of inflammatory bowel disease , 2018, Clinical Journal of Gastroenterology.

[21]  M. Wiciński,et al.  Nocardia spp. – characteristics, pathogenicity, treatment , 2018, Postępy Mikrobiologii - Advancements of Microbiology.

[22]  J. Ameh,et al.  Nutritional and sensory qualities of commercially and laboratory prepared orange juice , 2017 .

[23]  D. Underhill,et al.  Immunity to Commensal Fungi: Detente and Disease. , 2017, Annual review of pathology.

[24]  S. Vermeire,et al.  Bacteriome and Mycobiome Interactions Underscore Microbial Dysbiosis in Familial Crohn’s Disease , 2016, mBio.

[25]  D. Underhill,et al.  Immunological Consequences of Intestinal Fungal Dysbiosis. , 2016, Cell host & microbe.

[26]  Ta-Chiang Liu,et al.  Genetics and Pathogenesis of Inflammatory Bowel Disease. , 2016, Annual review of pathology.

[27]  G. Liguori,et al.  Fungal Dysbiosis in Mucosa-associated Microbiota of Crohn's Disease Patients. , 2016, Journal of Crohn's & colitis.

[28]  Hugues Aschard,et al.  Fungal microbiota dysbiosis in IBD , 2016, Gut.

[29]  G. Liguori,et al.  Gut Fungal Microbiota: The Yin and Yang of Inflammatory Bowel Disease , 2015, Inflammatory bowel diseases.

[30]  A. Sivignon,et al.  Saccharomyces cerevisiae CNCM I-3856 Prevents Colitis Induced by AIEC Bacteria in the Transgenic Mouse Model Mimicking Crohn's Disease , 2015, Inflammatory bowel diseases.

[31]  Jenny Sauk,et al.  Disease-Specific Alterations in the Enteric Virome in Inflammatory Bowel Disease , 2015, Cell.

[32]  S. Ahrné,et al.  Immunological alteration and changes of gut microbiota after dextran sulfate sodium (DSS) administration in mice , 2014, Clinical and Experimental Medicine.

[33]  G. Veres,et al.  ESPGHAN Revised Porto Criteria for the Diagnosis of Inflammatory Bowel Disease in Children and Adolescents , 2013, Journal of pediatric gastroenterology and nutrition.

[34]  Jie-shou Li,et al.  Dysbiosis of Gut Fungal Microbiota is Associated With Mucosal Inflammation in Crohn’s Disease , 2013, Journal of clinical gastroenterology.

[35]  L. Dubuquoy,et al.  Modulation of Intestinal Inflammation by Yeasts and Cell Wall Extracts: Strain Dependence and Unexpected Anti-Inflammatory Role of Glucan Fractions , 2012, PloS one.

[36]  V. Young,et al.  Candida albicans and Bacterial Microbiota Interactions in the Cecum during Recolonization following Broad-Spectrum Antibiotic Therapy , 2012, Infection and Immunity.

[37]  D. Underhill,et al.  Interactions Between Commensal Fungi and the C-Type Lectin Receptor Dectin-1 Influence Colitis , 2012, Science.

[38]  K. Honda,et al.  The microbiome in infectious disease and inflammation. , 2012, Annual review of immunology.

[39]  R. Xavier,et al.  Genetics and pathogenesis of inflammatory bowel disease , 2011, Nature.

[40]  David C Wilson,et al.  Pediatric modification of the Montreal classification for inflammatory bowel disease: The Paris classification , 2011, Inflammatory bowel diseases.

[41]  Jun Ma,et al.  Activation of the innate immune receptor Dectin-1 upon formation of a “phagocytic synapse” , 2011, Nature.

[42]  P. Vandamme,et al.  Dysbiosis of the faecal microbiota in patients with Crohn's disease and their unaffected relatives , 2011, Gut.

[43]  M. Melhem,et al.  Five-year evaluation of bloodstream yeast infections in a tertiary hospital: the predominance of non-C. albicans Candida species. , 2010, Medical mycology.

[44]  L. Mcfarland.  Systematic review and meta-analysis of Saccharomyces boulardii in adult patients. , 2010, World journal of gastroenterology.

[45]  E. Seker.  Identification of Candida Species Isolated from Bovine Mastitic Milk and Their In Vitro Hemolytic Activity in Western Turkey , 2010, Mycopathologia.

[46]  Thierry Jouault,et al.  Candida albicans Colonization and ASCA in Familial Crohn's Disease , 2009, The American Journal of Gastroenterology.

[47]  J. Blanco,et al.  Molecular diversity of Escherichia coli in the human gut: New ecological evidence supporting the role of adherent‐invasive E. coli (AIEC) in Crohn's disease , 2009, Inflammatory bowel diseases.

[48]  N. Pace,et al.  Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases , 2007, Proceedings of the National Academy of Sciences.

[49]  J. Tiedje,et al.  Naïve Bayesian Classifier for Rapid Assignment of rRNA Sequences into the New Bacterial Taxonomy , 2007, Applied and Environmental Microbiology.

[50]  G. Quindós,et al.  Candida dubliniensis, a new fungal pathogen , 2002, Journal of basic microbiology.

[51]  S. Suh,et al.  A Case of Mixed Fungemia with Cryptococcus laurentii and Candida zeylanoides , 2001 .

[52]  D. Coleman,et al.  Candida dubliniensis: an emerging opportunistic pathogen. , 1997, Current topics in medical mycology.

[53]  H. Isenberg,et al.  Candida zeylanoides: another opportunistic yeast , 1991, Journal of clinical microbiology.

[54]  T. Gosiewski,et al.  Impact of biological treatment on intestinal microbiom in children with Crohn’s disease , 2018 .

[55]  R. Sartor,et al.  Roles for Intestinal Bacteria, Viruses, and Fungi in Pathogenesis of Inflammatory Bowel Diseases and Therapeutic Approaches. , 2017, Gastroenterology.

[56]  Abdullahi,et al.  Isolation and Identification Of Yeast Associated With Fermented Orange Juice , 2014 .